Related references
Note: Only part of the references are listed.Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis
Harikrishna Makani et al.
EUROPEAN HEART JOURNAL (2014)
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Brian Godman et al.
FRONTIERS IN PHARMACOLOGY (2014)
Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications
Andrew Martin et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2014)
Pharmacist-patient communication in Swedish community pharmacies
Erika Olsson et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2014)
PP062—Variable approaches in europe to the availability of generic losartan; implications for the future
B. Godman et al.
CLINICAL THERAPEUTICS (2013)
Assessing quality in cross-country comparisons of health systems and policies: Towards a set of generic quality criteria
Mirella Cacace et al.
HEALTH POLICY (2013)
Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries
B. Godman et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
Brian Godman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Generic atypical antipsychotic drugs in Belgium: their influence and implications
Brian Godman et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2013)
Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries
Ulrik Hesse et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future
Steven Simoens et al.
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH (2013)
Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
Caitriona Cahir et al.
BMC HEALTH SERVICES RESEARCH (2012)
Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure
Henrik Svanstrom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions
Vanda Markovic-Pekovic et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries
Anna Bucsics et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland
Marion Bennie et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?
Marija Kalaba et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2012)
The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries-an overview
Sabine Vogler
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2012)
Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach
Brian Godman et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2012)
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Lars L. Gustafsson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
European countries with small populations can obtain low prices for drugs: Lithuania as a case history
Kristina Garuoliene et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future
Luka Voncina et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Policies to enhance prescribing efficiency in Europe: findings and future implications
Brian Godman et al.
FRONTIERS IN PHARMACOLOGY (2011)
Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
Bjorn Wettermark et al.
HEALTH POLICY (2010)
Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database
Vera Vlahovic-Palcevski et al.
PHARMACY WORLD & SCIENCE (2010)
Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications
Diane McGinn et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction
Anna Coma et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2009)
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
Brian Godman et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2009)
Soft Regulations in Pharmaceutical Policy Making An Overview of Current Approaches and their Consequences
Bjorn Wettermark et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2009)
Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on
J. Usher-Smith et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Balancing big pharma's books
Andrew Jack
BRITISH MEDICAL JOURNAL (2008)
Insight into recent reforms and initiatives in Austria: implications for key stakeholders
Brian Godman et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2008)
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
Balraj S. Heran et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
What are the obstacles to generic substitution?: An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden
K Andersson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Segmented regression analysis of interrupted time series studies in medication use research
AK Wagner et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2002)
Different versions of the anatomical therapeutic chemical classification system and the defined daily dose - are drug utilisation data comparable?
M Ronning et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
